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Abstract
Leveraging large historical data in electronic health record (EHR), we developed Doctor AI, a
generic predictive model that covers observed medical conditions and medication uses. Doctor
AI is a temporal model using recurrent neural networks (RNN) and was developed and applied
to longitudinal time stamped EHR data from 260K patients over 8 years. Encounter records
(e.g. diagnosis codes, medication codes or procedure codes) were input to RNN to predict (all)
the diagnosis and medication categories for a subsequent visit. Doctor AI assesses the history
of patients to make multilabel predictions (one label for each diagnosis or medication category).
Based on separate blind test set evaluation, Doctor AI can perform differential diagnosis with
up to 79% recall@30, significantly higher than several baselines. Moreover, we demonstrate great
generalizability of Doctor AI by adapting the resulting models from one institution to another
without losing substantial accuracy.
1. Introduction
A common challenge in healthcare today is that physicians have access to massive amounts of
data on patients, but little time nor tools. Intelligent clinical decision support anticipates the
information at the point of care that is specific to the patient and provider needs. Electronic health
records (EHR), now commonplace in U.S. healthcare, represent the longitudinal experience of both
patients and doctors. These data are being used with increasing frequency to predict future events.
While predictive models have been developed to anticipate needs, most existing work has focused on
specialized predictive models that predict a limited set of outcomes. However, day-to-day clinical
practice involves an unscheduled and heterogeneous mix of scenarios and needs different prediction
models in the hundreds to thousands. It is impractical to develop and deploy specialized models
one by one.
Leveraging large historical data in EHR, we developed Doctor AI, a generic predictive model
that covers observed medical conditions and medication uses. Doctor AI is a temporal model using
recurrent neural networks (RNN) and was developed and applied to longitudinal time stamped
EHR data. In this work, we are particularly interested in whether historical EHR data may be
used to predict future physician diagnoses and medication orders. Applications that accurately
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forecast could have many uses such as anticipating the patient status at the time of visit and
presenting data a physician would want to see at the moment. The primary goal of this study was
to use longitudinal patient visit records to predict the physician diagnosis and medication order of
the next visit. As a secondary goal we predicted the time to the patients next visit. Predicting the
visit time facilitates guidance of whether a patient may be delayed in seeking care.
The two tasks addressed in this work are different from sequence labeling tasks often seen in
natural language processing applications, e.g., part-of-speech tagging. Our proposed model, Doctor
AI, performs multilabel prediction (one for each disease or medication category) over time while
sequence labeling task predicts a single label at each step. The key challenge was finding a flexible
model that is capable of performing the multilabel prediction problem. The two main classes of
techniques have been proposed in dealing with temporal sequences: 1) continuous-time Markov
chain based models (Nodelman et al., 2002; Lange et al., 2015; Johnson and Willsky, 2013), and 2)
intensity based point process modeling techniques such as Hawkes processes (Liniger, 2009; Zhu,
2013; Choi et al., 2015). However, both classes are expensive to compute, especially for nonlinear
settings. Furthermore, they often make strong assumptions about the data generation process which
might not be valid for EHR data. Our modeling strategy was to develop a generalized approach
to representing patient temporal healthcare experience to predict all the diagnoses, medication
categories and visit time. We used recurrent neural network (RNN), considering that RNNs have
been particularly successful for representation learning in sequential data, e.g. Graves (2013);
Graves and Jaitly (2014); Sutskever et al. (2014); Kiros et al. (2014); Zaremba and Sutskever
(2014). In particular, we make the following main contributions in this paper:
• We demonstrate how RNNs can be used to represent the patient status and predict diagnosis,
medication order and visit time. The trained RNN is able to achieve above 64% recall@10 and
79% recall@30 for diagnosis prediction, showing potential to serve as a differential diagnosis
assistance.
• We propose an initialization scheme for RNNs using Skip-gram embeddings (Mikolov et al.,
2013) and show that it improves the performance of the RNN in both accuracy and speed.
• We empirically confirm that RNN models possess great potential for transfer learning across
different medical institutions. This suggests that health systems with insufficient patient data
can adopt models learned from larger datasets of other health systems to improve prediction
accuracy on their smaller population.
2. Related Work
In this section, we briefly review the common approaches to modeling multilabel event sequences
with special focus on the models that have been applied to medical data. There are two main
approaches to modeling multilabel event sequences: with or without discretization (binning) of
time.
Discretization. When the time axis is discretized, the point process data can be converted
to binary time series (or time series of count data if binning is coarse) and analyzed via time
series analysis techniques (Truccolo et al., 2005; Bahadori et al., 2013; Ranganath et al., 2015).
However, this approach is inefficient as it produces long time series whose elements are mostly zero.
Furthermore, discretization of time introduces noise in the time stamps of visits. Finally, these
approaches are often not able to model the duration until next event. Thus, it is advantageous not
to discretize the data both in terms of modeling and computation.
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Continuous-time models. Among the continuous-time models, there are two main techniques:
continuous-time Markov chain based models (Foucher et al., 2007; Johnson and Willsky, 2013;
Lange, 2014; Liu et al., 2013) and their extension using Baysian networks (Nodelman et al., 2002;
Weiss et al., 2012) and intensity function modeling techniques such as Cox and Hawkes processes
(Liniger, 2009; Zhou et al., 2013; Linderman and Adams, 2014; Choi et al., 2015).
Intensity function modeling techniques have been shown to have computational advantages over
the continuous-time Markov chain based models. Moreover, modeling multilabel marked point
processes with continuous-time Markov chains expands their state-space and make them even more
expensive. However, Hawkes processes only depend linearly on the past observation times; while
there are limited classes of non-linear Hawkes process (Zhu, 2013), the temporal dynamics can
be more complex. Finally, Hawkes processes are known to have a flat loss function near optimal
value of the parameters which renders the gradient-based learning algorithms inefficient (Veen and
Schoenberg, 2008). In this paper we address these challenges by designing a recurrent neural
network which has been shown to be successful in learning complex sequential patterns.
Disease progression models. There have been active research in modeling the temporal pro-
gression of diseases (Mould, 2012). Generally, most works can be divided into two groups: works
that focus on a specific disease and works that focus on a broader range of diseases.
Specific-purpose progression modeling: There have been many studies that focus on modeling
the temporal progression of a specific disease based on either intensive use of domain-specific
knowledge (De Winter et al., 2006; Ito et al., 2010; Tangri et al., 2011) or taking advantage of
advanced statistical methods (Liu et al., 2013; Jackson et al., 2003; Sukkar et al., 2012; Zhou et al.,
2012). Specifically, studies have been conducted on Alzheimer’s disease (Ito et al., 2010; Zhou et al.,
2012; Sukkar et al., 2012), glaucoma (Liu et al., 2013), chronic kidney disease (Tangri et al., 2011),
diabetes mellitus (De Winter et al., 2006), and abdominal aortic aneurysm (Jackson et al., 2003)
General-purpose progression modeling: Recently, Wang et al. (2014); Choi et al. (2015); Ran-
ganath et al. (2015) proposed more general approaches to modeling the progression of wider range
of diseases. As discussed earlier, Choi et al. (2015) used Hawkes process, and Ranganath et al.
(2015) discretized time in order to model multiple patients and multiple diseases. Wang et al.
(2014) proposed a graphical model based on Markov Jump Process to predict the stage progression
of chronic obstructive pulmonary disease (COPD) and its co-morbid diseases.
One of the main challenges in using these algorithms is scalability. The datasets used in previous
works typically contain up to a few thousands of patients and a few hundreds of codes. Even the
largest dataset used by Ranganath et al. (2015) contains 13,180 patients and 8,722 codes, which
is significantly smaller than our dataset described in Table 1. Need for domain-specific knowledge
is also a big challenge. For example, Wang et al. (2014) not only used a smaller dataset (3,705
patients and 264 codes) but also used co-morbidity information to improve the performance of their
algorithm. Such expert knowledge is difficult to obtain from typical EHR data.
Deep learning models for EHR. Researchers have recently begun attempting to apply neural
network based methods (or deep learning) to EHR to utilize its ability to learn complex patterns
from data. Previous studies such as phenotype learning (Lasko et al., 2013; Che et al., 2015;
Hammerla et al., 2015) or representation learning (Choi et al., 2016b,a; Miotto et al., 2016), however,
have not fully addressed the sequential nature of EHR. Lipton et al. (2016) is especially related
to our work in that both studies use RNN for sequence prediction. However, while Lipton et al.
(2016) uses regular times series of real-valued variables collected from ICU patients to predict
diagnosis codes, we use discrete medical codes (e.g. diagnosis, medication, procedure) extracted
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Table 1: Basic statistics of the the clinical records dataset.
# of patients 263,706 Total # of codes 38,594
Avg. # of visits 54.61 Total # of 3-digit Dx codes 1,183
Avg. # of codes per visit 3.22 # of top level Rx codes 595
Max # of codes per visit 62 Avg. duration between visits 76.12 days
from longitudinal patient visit records. Also, in each visit we make a prediction about predict
diagnosis, medication order in the next visit and and the time to next visit.
3. Cohort
Population and source of data. The source population for this study was primary care patients
from Sutter Health Palo Alto Medical Foundation. Sutter Health is a large primary care and
multispecialty group practice that has used an Epic Systems Corporation EHR for more than a
decade. The dataset was extracted from a density sampled case-control study for heart failure.
The dataset consists of de-identified encounter orders, medication orders, problem list records and
procedure orders.
Data processing. As inputs, we use ICD-9 codes, medication codes, and procedure codes. We
extracted ICD-9 codes from encounter records, medication orders, problem list records and proce-
dure orders. Generic Product Identifier (GPI) medication codes and CPT procedure codes were
extracted from medication orders and procedure orders respectively. All codes were timestamped
with the patients visit time. If a patient received multiple codes in a single visit, those codes were
given the same timestamp. We excluded patients that made less than two visits. The resulting
dataset consists of 263,706 patients who made on average 54.61 visits per person.
Grouping medical codes. There are more about 11,000 unique ICD-9 codes and 18,000 GPI
medication codes in the dataset, many of which are very granular. For example, pulmonary tuber-
culosis (ICD-9 code 011) is divided into 70 subcategories (ICD-9 code 011.01, 011.02, ..., 011.95,
011.96). Simply knowing that a patient is likely to have pulmonary tuberculosis is enough to
increase the doctor’s awareness of the severity of the clinical situation. Therefore, to predict di-
agnosis and medication order, we grouped codes into higher-order categories to reduce the feature
set and information overload. For the diagnosis codes, we use the 3-digit ICD-9 codes, yielding
1183 unique codes. For the medication codes, we use the Generic Product Identifier Drug Class,
which groups the medication codes into 595 unique groups. The label yi we use in the following
sections represents the 1,778-dimensional vector (i.e., 1183 + 595) for the grouped diagnosis codes
and medication codes.
4. Methods
This section describes the RNN model for multilabel point processes. We will also describe how we
predict diagnosis, medication order and visit time using the RNN model.
Problem setting. For each patient, the observations are drawn from a multilabel point process in
the form of (ti,xi) for i = 1, . . . , n. Each pair represents an event, such as an ambulatory care visit,
during which multiple medical codes such as ICD-9 diagnosis codes, procedure codes, or medication
codes are documented in the patient record. The multi-hot label vector xi ∈ {0, 1}p represents the
medical codes assigned at time ti, where p denotes the number of unique medical codes. At each
timestamp, we may extract higher-level codes for prediction purposes and denote it by yi, see the
details in Section 3. The number of events for each patient may differ.
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Figure 1: This diagram shows how we have applied RNNs
to solve the problem of forecasting of next visits’ time and
the codes assigned during each visit. The first layer simply
embeds the high-dimensional input vectors in a lower dimen-
sional space. The next layers are the recurrent units (here
two layers), which learn the status of the patient at each
timestamp as a real-valued vector. Given the status vector,
we use two dense layers to generate the codes observed in
the next timestamp and the duration until next visit. 𝒙" 𝒙#$" 𝒙#
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Gated Recurrent Units Preliminaries. Specifically, we implemented our RNN with Gated Re-
current Units (GRU). Although Long Short Term Memory (LSTM) (Hochreiter and Schmidhuber,
1997; Graves et al., 2009) has drawn much attention from many researchers, GRU has recently
shown to have similar performance as LSTM, while employing a simpler architecture (Chung et al.,
2014). In order to precisely describe the network used in this work, we reiterate the mathematical
formulation of GRU as follows:
zi = σ(Wzxi +Uzhi−1 + bz)
ri = σ(Wrxi +Urhi−1 + br)
h˜i = tanh(Whxi + ri ◦Uhhi−1 + bh)
hi = zi ◦ hi−1 + (1− zi) ◦ h˜i
where zi and ri respectively represent the update gate and the reset gate, h˜i the intermediate
memory unit, hi the hidden layer, all at timestep ti. A detailed description of GRU is provided in
Appendix A.
Description of neural network architecture. Our goal is to learn an effective vector repre-
sentation for the patient status at each timestamp ti. Using effective patient representations, we
are interested in predicting diagnosis and medication categories in the next visit yi+1 and the time
duration until the next visit di+1 = ti+1 − ti. Finally, we would like to perform all these steps
jointly in a single supervised learning scheme. We use RNN to learn such patient representations,
treating the hidden layer as the representation for the patient status and use it for the prediction
tasks.
The proposed neural network architecture (Figure 1) receives input at each timestamp ti as
the concatenation of the multi-hot input vector xi of the multilabel categories and the duration di
since the last event. In our datasets, the input dimension is as large as 40, 000. Thus, the next
layer projects the input to a lower dimensional space. Then, we pass the lower dimensional vector
through RNN (implemented with GRU in our study). We can also stack multiple layers of RNN
to increase the representative power of the network. Finally, we use a Softmax layer to predict the
diagnosis codes and the medication codes, and a rectified linear unit (ReLU) to predict the time
duration until next visit.
For predicting the diagnosis codes and the medication codes at each timestep ti, a Softmax layer
is stacked on top of the GRU, using the hidden layer hi as the input: ŷi+1 = softmax(Wcode
>hi +
bcode). For predicting the time duration until the next visit, a rectified linear unit (ReLU) is placed
on top of the GRU, again using the hidden layer hi as the input: d̂i+1 = max(wtime
>hi + btime, 0).
The objective of training our model is to learn the weights W{z,r,h,code}, U{z,r,h}, b{z,r,h,code}, wtime
and btime. The values of all W ’s and U ’s were initialized to orthonormal matrices using singular
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value decomposition of matrices generated from the normal distribution (Saxe et al., 2013). The
initial value of wtime was chosen from the uniform distribution between −0.1 and 0.1. All b’s and
btime were initialized to zeros. The joint loss function consists of the cross entropy for the code
prediction and the squared loss for the time duration prediction, as described below for a single
patient:
L(W ,U , b,wtime, btime) =
n−1∑
i=1
{(
yi+1 log(ŷi+1) + (1− yi+1) log(1− ŷi+1)
)
+
1
2
‖di+1 − d̂i+1‖22
}
As mentioned above, the multi-hot vectors xi of almost 40,000 dimensions are first projected to a
lower dimensional space, then put into the GRU. We employed two different approaches for this:
(1) We put an extra layer of a certain size between the multi-hot input xi and the GRU, and call
it the embedding layer. We denote the weight matrix between the multi-hot input vector and the
embedding layer as Wemb. Then we learn the weight Wemb as we train the entire model. (2) We
initialize the weight Wemb with a matrix generated by Skip-gram algorithm (Mikolov et al., 2013),
then refine the weight Wemb as we train the entire model. This can be seen as using the pre-trained
Skip-gram vectors as the input to the RNN and fine-tuning them with the joint prediction task.
The brief description of learning the Skip-gram vectors from the EHR is provided in Appendix B.
The first and second approach can be formulated as follows:
h
(1)
i = [tanh(xi
>Wemb + bemb), di] (1)
h
(1)
i = [xi
>Wemb, di] (2)
where [·, ·] is the concatenation operation used for appending the time duration to the multi-hot
vector h
(1)
i to make it an input vector to the GRU.
5. Results
We now describe the details of our experiments in the proposed RNN approach to forecasting the
future clinical events. The source code of Doctor AI is publicly available at https://github.com/
mp2893/doctorai.
5.1 Experiment Setup
For training all models including the baselines, we used 85% of the patients as the training set
and 15% as the test set. We trained the RNN models for 20 epochs (i.e., 20 iterations over the
entire training data) and then evaluated the final performance against the test set. To avoid
overfitting, we used dropout between the GRU layer and the prediction layer (i.e. code prediction
and time duration prediction). Dropout was also used between GRU layers if we were using a multi-
layer GRU. We also applied norm-2 regularization on both Wcode and wtime. Both regularization
coefficients were set to 0.001. The size of the hidden layer hi of the GRU was set to 2000 to
guarantee a sufficient expressive power. After running sets of preliminary experiments where we
tried the size from 100 to 2000, we noticed that the code prediction performance started to saturate
around 1600∼1800. All models were implemented with Theano (Bastien et al., 2012) and trained
on a machine equipped with two Nvidia Tesla K80 GPUs.
We train total four different variation of Doctor AI as follows,
• RNN-1: RNN with a single hidden layer initialized with a random orthogonal matrix for
Wemb.
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• RNN-2: RNN with two hidden layers initialized with a random orthogonal matrix for Wemb.
• RNN-1-IR: RNN using a single hidden layer initialized embedding matrix Wemb with the
Skip-gram vectors trained on the entire dataset.
• RNN-2-IR: RNN with two hidden layers initialized embedding matrix Wemb with the Skip-
gram vectors trained on the entire dataset. dataset.
5.2 Evaluation metrics
The performance of algorithms in predicting diagnoses and medication codes was evaluated using
the Top-k recall defined as:
top-k recall =
# of true positives in the top k predictions
# of true positives
Top-k recall mimics the behavior of doctors conducting differential diagnosis, where doctors list
most probable diagnoses and treat patients accordingly to identify the patient status. Therefore,
a machine with a high Top-k recall translates to a doctor with an effective diagnostic skill. This
makes Top-k recall an attractive performance metric for our problem.
We select the maximum k to be 30 to evaluate the performance of the models not only for
simple cases but also for complex cases. Near 50.7% of the patients have been assigned with more
than 10 diagnosis and medication codes at least once. Since it is those complex cases that are of
interest to predict and analyze, we choose k to be large enough (i.e., 3 times of the mean).
Coefficient of determination (R2) was used to evaluate the predictive performance of re-
gression and forecasting algorithms. It compares the accuracy of the prediction with respect to the
simple prediction by mean of the target variable.
R2 = 1−
∑
i (yi − ŷi)2∑
i (yi − yi)2
Because time to the next visit can be highly skewed, we measure the R2 performance of the
algorithms in predicting log(di) to lower the impact of anomalous long durations in the performance
metric. In the same spirit, we train all models to predict the logarithm of the time duration between
visits.
5.3 Baselines
We compare our model against several baselines as described below. Some of the existing techniques
based on continuous-time Markov chain and latent space models were not scalable enough to be
trained using the entire dataset in a reasonable amount of time; thus comparison is not feasible.
Frequency baselines. We compare our algorithms against simple baselines that are based on
experts’ intuition about the dynamics of events in clinical settings. The first baseline uses a patient’s
medical codes in the last visit as the prediction for the current visit. This baseline is competitive
when the status of a patient with a chronic condition stabilizes over time. We enhanced this
baseline using the top-k most frequent labels observed in visits prior to the current visits. In the
experiments we observe that the baseline of top-k most frequent labels is quite competitive.
Logistic and Neural Network time series models. A common way to perform prediction
task is to use xi−1 to predict the codes in the next visit xi using logistic regression or multilayer
perceptron (MLP). To enhance the baseline further, we can use the data from L time lags before
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Table 2: Accuracy of algorithms in forecasting future medical activities. Embedding matrices Wemb
of both RNN-1 (using one hidden layer) and RNN-2 (using two hidden layers) are initialized with
random orthogonal vectors. Embedding matrices Wemb of both RNN-1-IR (using one hidden layer)
and RNN-2-IR (using two hidden layers) are initialized with Skip-gram vectors trained on the entire
dataset.
Dx Only Recall @k Rx Only Recall @k Dx,Rx,Time Recall @k
Algorithms k = 10 k = 20 k = 30 k = 10 k = 20 k = 30 k = 10 k = 20 k = 30 R2
Last visit 29.17 13.81 26.25 —
Most freq. 56.63 67.39 71.68 62.99 69.02 70.07 48.11 60.23 66.00 —
Logistic 43.24 54.04 60.76 45.80 60.02 68.93 36.04 46.32 52.53 0.0726
MLP 46.66 57.38 64.03 47.62 61.72 70.92 38.82 49.09 55.74 0.1221
RNN-1 63.12 73.11 78.49 67.99 79.55 85.53 53.86 65.10 71.24 0.2519
RNN-2 63.32 73.32 78.71 67.87 79.47 85.43 53.61 64.93 71.14 0.2528
RNN-1-IR 63.24 73.33 78.73 68.31 79.77 85.52 54.37 65.68 71.85 0.2492
RNN-2-IR 64.30 74.31 79.58 68.16 79.74 85.48 54.96 66.31 72.48 0.2534
and aggregate them xi−1 +xi−2 + ,+xi−L for some duration L to create the features for prediction
of xi. Similarly, we can have a model that predicts the time until next visit using rectified linear
units (ReLU) as the output activation. We set the lag L = 5 so that the logistic regression and
MLP can use information from maximum five past visits. The details of MLP design are described
in Appendix C.
5.4 Prediction performance
Table 2 compares the results of different algorithms with RNN based Doctor AI. We report the
results in three settings: when we are interested in (1) predicting only diagnosis codes (Dx), (2)
predicting only medication codes (Rx), and (3) jointly predicting Dx codes, Rx codes, and the time
duration to next visit. The results confirm that the proposed approach is able to outperform the
baseline algorithms by a large margin. Note that the recall values for the joint task are lower than
those for Dx code prediction or Rx code prediction because the hypothesis space is larger for the
joint prediction task.
The superior performance of RNN based approaches can be attributed to the efficient represen-
tation that they learn for patients at each visit (Bengio et al., 2013; Schmidhuber, 2015). RNNs
are able to learn succinct feature representations of patients by accumulating the relevant informa-
tion from their history and the current set of codes, which outperformed hand-picked features of
frequency baselines.
Table 2 confirms that learning patient representation with RNN is easier with the input vec-
tors that are already efficient representations of the medical codes. The RNN trained with the
Skip-gram vectors (denoted by RNN-IR) consistently outperforms the RNN that learns the weight
matrix Wemb directly from the data, with only one exception, the medication prediction Recall@30,
although the differences are insignificant. The results also confirm that having multiple layers when
using RNN improves its ability to learn more efficient representations. The results also indicate that
a single layer RNN might have enough representative power to capture the dynamics of medications,
and adding more layers may not improve the performance.
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The results also indicate that our approach significantly improves the accuracy of predicting
the time duration until the next visit compared to the baselines. However, the absolute value of
R2 metric shows that accurate prediction of time intervals remains as a challenge. We believe
achieving significantly better time prediction without extra features should be difficult because the
timing of a clinical visit can be affected by many personal factors such as financial status, location
of residence, means of transportation, and life style, to name a few. Thus, without such sensitive
personal information, which is rarely included in the EHR, accurate prediction of time intervals
should be unlikely.
5.5 Understanding the behavior of the network
To study the applicability of our model in a real-world setting where patients have varying length
of medical records, we conducted an additional experiment to study the relationship between the
length of the patient medical history and the prediction performance. To this end, we selected
5,800 patients from the test set who had more than 100 visits. We used the best performing model
to predict the diagnosis codes at visits at different times and found the mean and standard error of
recall across the selected patients. Figure 2a shows the result of the experiment. We believe that
the increase in performance can be due to two reasons: (1) RNN is able to learn a better estimate
of the patient status as it sees longer patient records and (2) Visits are correlated with poor health.
Those with high visit count are more likely to be severely ill, and therefore their future is easier to
predict.
Another experiment was conducted to understand the behavior of the network by giving syn-
thetic inputs. We chose hypertension (ICD-9 code 401.9) as an example of a frequently observed
diagnosis, and Klinefelter’s syndrome (ICD-9 code 758.7) as an example of an infrequent diagnosis.
We created two synthetic patients who respectively have 200 visits of 401.9 and 758.7. Then we
used the best performing model to predict the diagnosis codes for the next visits. Figure 2b shows
contrasting patterns: when the input is one of the frequent codes such as hypertension, the network
quickly learns a more specific set of output codes as next disease. When we select an infrequent
code like Klinefelter’s syndrome as the input, the network’s output is more diverse and mostly the
frequently observed codes. The top 30 codes after convergence shown in Table 4 in Appendix D
confirm the disparity of the diversity of the predicted codes for the two cases.
5.6 Knowledge transfer across hospitals
As we observed from the previous experiments, the dynamics of clinical events are complex, which
requires models with a high representative power. However, many institutions have not yet col-
lected large scale datasets, and training such models could easily lead to overfitting. To address
this challenge, we resort to the recent advances in domain adaptation techniques for deep neural
networks (Mesnil et al., 2012; Bengio, 2012; Yosinski et al., 2014; Hoffman et al., 2014).
A different dataset, MIMIC II, which is a publicly available clinical dataset collected from ICU
patients over 7 years of observation, was chosen to conduct the experiment. This dataset differs
from the Sutter dataset in that it consists of demographically and diagnostically different patients.
The number of patients who made at least two visits is 2,695, and the number of unique diagnosis
code (3-digit ICD-9 code) is 767, which is a subset of the Sutter dataset. From the dataset, we
extracted sequences of 3-digit ICD-9 codes. We chose 2,290 patients for training, 405 for testing.
We chose the 2-layer RNN with 1000 dimensional hidden layer, and performed two experiments:
1) We trained the model only on the MIMIC II dataset. 2) We initialized the coefficients of the
model with the values learned from the 3-digit ICD-9 sequences of the Sutter data, then we refined
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Figure 2: Characterizing behavior of the trained network: (a) Prediction performance of Doctor AI
as it sees a longer history of the patients. (b) Change in the perplexity of response to a frequent
code (hypertension) and an infrequent code (Klinefelter’s syndrome).
Figure 3: The impact of pre-training
on improving the performance on smaller
datasets. In the first experiment, we first
train the model on a small dataset (red
curve). In the second experiment, we pre-
train the model on our large dataset and
use it for initializing the training of the
smaller dataset. This procedure results in
more than 10% improvement in the per-
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the coefficients with the MIMIC II dataset. Figure 3 shows the vast improvement of the prediction
performance induced by the knowledge transfer from the Sutter data.
6. Conclusion
In this work, we proposed Doctor AI system, which is a RNN-based model that can learn efficient
patient representation from a large amount of longitidinal patient records and predict future events
of patients. We tested Doctor AI on a large real-world EHR datasets, which achieved 79.58% re-
call@30 and significantly outperformed many baselines. We have also shown that the patient’s visit
count and the rarity of medical codes highly influence the performance. We have also demonstrated
that knowledge learned from one hospital could be adapted to another hospital. The empirical anal-
ysis by a medical expert confirmed that Doctor AI not only mimics the predictive power of human
doctors, but also provides diagnostic results that are clinically meaningful.
One limitation of Doctor AI is that, in medical practice, incorrect predictions can sometimes
be more important than correct predictions as they can degrade patient health. Also, although
Doctor AI has shown that it can mimic physicians’ average behavior, it would be more useful to
learn to perform better than average. We set as our future work to address these issues so that
Doctor AI can provide practical help to physicians in the future.
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Appendices
Appendix A. Description of Gated Recurrent Units
xi
hi-1 hihi
~
ri zi Element-wise multiplication
Element-wise AdditionWr Wz
Ur
Uz
Wh
Uh
1-zi zi
Values are directly propagated
Values are modified by weights
Figure 4: Architecture of GRU
We first reiterate the mathematical formulation of GRU so that the reader can see Figure 4 and
the formulations together.
zi = σ(Wzxi +Uzhi−1 + bz)
ri = σ(Wrxi +Urhi−1 + br)
h˜i = tanh(Whxi + ri ◦Uhhi−1 + bh)
hi = zi ◦ hi−1 + (1− zi) ◦ h˜i
Figure 4 depicts the architecture of the GRU, where xi, zi and ri respectively represent the input,
update gate and the reset gate, h˜i the intermediate memory unit, hi the hidden layer, all at
timestep ti. Wh,Wz,Wr,Uh,Uz,Ur are the weight matrices to be learned. Note that the bias
vectors bh, bz, br are omitted in Figure 4.
The outstanding difference between the classical RNN (Elman Network) and GRU is that the
previous hidden layer hi−1 and the current input xi do not directly change the value of the current
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hidden layer hi. Instead, they change the values of both gates zi, ri and the intermediate memory
unit h˜i. Then the current hidden layer hi is updated by h˜i and zi. Due to the σ function, both
gates zi and ri have values between 0 and 1. Therefore if the reset gate ri is close to zero, the
intermediate memory unit h˜i will disregard the past values of the hidden layer hi−1. If the update
gate zi is close to one, the current hidden layer hi will disregard the current input xi, and retain
the value from the previous timestep hi−1.
Simply put, the reset gate allows the hidden layer to drop any information that is not useful
in making a prediction, and the updated gate controls how much information from the previous
hidden layer should be propagated to the current hidden layer. This characteristic of GRU is
especially useful as it is not easy to identify information essential to predicting the future diagnosis,
medication or the time duration until the next visit.
Appendix B. Learning the Skip-gram vectors from the EHR
Learning efficient representations of medical codes (e.g. diagnosis codes, medication codes, and
procedure codes) may lead to improved performance of many clinical applications. We specifically
used Skip-gram Mikolov et al. (2013) to learn real-valued multidimensional vectors to capture the
latent representation of medical codes from the EHR.
We processed the private dataset so that diagnosis codes, medication codes, procedure codes
are laid out in a temporal order. If there are multiple codes at a single visit, they were laid out in a
random order. Then using the context window size of 5 to the left and 5 to the right, and applying
Skip-gram, we were able to project diagnosis codes, medication codes and procedure codes into the
same lower dimensional space, where similar or related codes are embedded close to one another.
For example, hypertension, obesity, hyperlipidemia all share similar values compared to pneumonia
or bronchitis. The trained Skip-gram vectors are then plugged into RNN so that a multi-hot vector
can be converted to vector representations of medical codes.
Appendix C. Details of the training procedure of multilayer perceptron
We use a multilayer perceptron with a hidden layer of width 2,000. We apply L2 regularization to
all of the weight matrices. The activation functions in the first and output layers are selected to be
tanh and softmax functions respectively. For prediction of time intervals, we used rectified linear
units.
Appendix D. Case study
The detailed results are shown in Table 3. To take a closer look at the performance of Doctor AI,
in Table 3 (in Appendix D) we list the predicted, true, and historical diagnosis codes for five visits
of different patients. The blue items represent the correct predictions. The results are promising
and show that, given the history of the patient, the Doctor AI can predict the true diagnostic
codes. The results highly mimic the way a human doctor will interpret the disease predictions from
the history. For all five of the cases shown in Table 3, the set of predicted diseases contain most,
if not all of the true diseases. For example, in the first case, the top 3 predicted diseases match
the true diseases. A human doctor would likely predict similar diseases to the ones predicted with
Doctor AI, since old myocardial infarction and chronic ischemic heart disease can be associated
with infections and diabetes (Stevens et al., 1978).
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In the fourth case, visual disturbances can be associated with migraines and essential hyper-
tension (Keith et al., 1939). Further, essential hypertension may be linked to cognitive function
(Kuusisto et al., 1993), which plays a role in anxiety disorders and dissociative and somatoform dis-
orders. Regarding codes that are guessed incorrectly with the fourth case, they can still be plausible
given the history. For example, cataracts, and disorders of refraction and accommodation could
have been guessed based on a history of visual disturbances, as well as strabismus and disorders of
binocular eye movements. Allergic rhinitis could have been guessed, because there was a history
of allergic rhinitis. In summary, Doctor AI is able to very accurately predict the true diagnoses in
the sample patients. The results are promising and should motivate future studies involving the
application of Doctor AI on different datasets exhibiting other populations of patients.
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